Patents involving antibody medicines (antibody patents) are largely grouped into patents specified by antibody amino acid sequences (antibody sequence-based patents) and those not (non-sequence-based patents). Non-sequence-based patents have a broad scope and are thus very useful for protecting antibody medicines. Here, I investigate a recent trend in antibody patents characterized by an antibody-binding site in an antigen.
Case Study: Recently Granted Epitope-Based Antibody Patents in the United States, Europe and Japan
No Comments
Patent
- Enablement
- Fee Shifting
- Litigation
- Other Barks & Bites for Friday, December 4: FTC Issues Hatch-Waxman Patent Settlement Report, Germany Approves Unified Patent Court and Bipartisan Entrepreneurship Bill Introduced in Congress
- Amicus eComp Consultants Urges Supreme Court to Deem PTAB APJs ‘Inferior’ Officers in Arthrex
- Response Filed to SCOTUS Petition on Question of Whether Reserve Banks Are ‘Persons’ Eligible to Request PTAB Review
- Supreme Court Ponders Proper Application of the Computer Fraud and Abuse Act
- A Swing (and a Miss) at NIH Tech Transfer
Recent Posts
- Other Barks & Bites for Friday, December 4: FTC Issues Hatch-Waxman Patent Settlement Report, Germany Approves Unified Patent Court and Bipartisan Entrepreneurship Bill Introduced in Congress
- Amicus eComp Consultants Urges Supreme Court to Deem PTAB APJs ‘Inferior’ Officers in Arthrex
- Response Filed to SCOTUS Petition on Question of Whether Reserve Banks Are ‘Persons’ Eligible to Request PTAB Review
- Supreme Court Ponders Proper Application of the Computer Fraud and Abuse Act
- A Swing (and a Miss) at NIH Tech Transfer